...
首页> 外文期刊>European journal of clinical nutrition >Comparison of the efficacy of Nutritional Risk Screening 2002 and Mini Nutritional Assessment Short Form in recognizing sarcopenia and predicting its mortality
【24h】

Comparison of the efficacy of Nutritional Risk Screening 2002 and Mini Nutritional Assessment Short Form in recognizing sarcopenia and predicting its mortality

机译:营养风险筛查2002和迷你营养评估短期患者患有嗜血症患者的疗效和预测其死亡率的疗效比较

获取原文
获取原文并翻译 | 示例

摘要

Objective This study aimed to examine the efficacy of Nutritional Risk Screening 2002 (NRS2002) and Mini Nutritional Assessment Short Form (MNA-SF) in recognizing sarcopenia and predicting its mortality in Chinese geriatric hospitalized patients. Methods A prospective analysis was performed in 430 hospitalized geriatric patients. Nutrition status was assessed using the NRS2002 and MNA-SF scales. Anthropometric measures and biochemical parameters were carried out for each patient. Sarcopenia was defined according to the revised consensus definition of the European Working Group on Sarcopenia in Older People (EWGSOP2). Patients were follow-up for up to 26 months. Results The overall prevalence of sarcopenia was 35.3% in this population. In the sarcopenic patients, 53 (34.9%) were malnutrition/nutritional risk according to NRS2002 assessment and 101 (66.4%) patients were malnutrition/nutritional risk according to MNA-SF assessment. NRS2002 vs MNA-SF showed moderate agreement (kappa = 0.460,P < 0.001). Receiver operating characteristic analysis showed that the area under the curve of MNA-SF was larger than NRS2002 in recognizing sarcopenia (0.763 vs 0.649,P = 0.001). During a median follow-up time of 20.22 months, 48 (31.6%) sarcopenic patients died. The Kaplan-Meier curve demonstrated that malnutrition/nutritional risk patients according to whether NRS2002 or MNA-SF assessment had a higher risk of death than the normal nutrition patients (chi(2) = 15.728,P < 0.001;chi(2) = 7.039,P = 0.008, respectively). Age, serum albumin levels, and NRS2002 score were independent factors influencing the mortality. Conclusion MNA-SF score may be better than the NRS2002 score to recognize sarcopenia in Chinese geriatric population. Both NRS2002 and MNA-SF scores could predict mortality, but NRS2002 score was the independent predict factor.
机译:目的本研究旨在探讨营养风险筛查2002(NRS2002)和迷你营养评估短症(MNA-SF)识别康​​迟腺增强患者的疗效培训和迷你营养评估的疗效。方法在430名住院病人中进行前瞻性分析。使用NRS2002和MNA-SF刻度评估营养状态。对每位患者进行人体测量措施和生化参数。根据老年人(EWGSOP2)的SARCOPENIA对欧洲工作组的修订义务定​​义进行了定义。患者随访长达26个月。结果康迟病毒的总体流行率为35.3%。在狭龄癌中,根据NRS2002评估,53名(34.9%)是营养不良/营养风险,并根据MNA-SF评估,101名(66.4%)患者是营养不良/营养风险。 NRS2002 VS MNA-SF显示中等协议(Kappa = 0.460,P <0.001)。接收器操作特征分析表明,MNA-SF曲线下的面积大于NRS2002识别SARCOPENIA(0.763 Vs 0.649,P = 0.001)。在20.22个月的中位后续时间,48例(31.6%)嗜睡患者死亡。 Kaplan-Meier曲线展示了营养不良/营养风险患者根据NRS2002或MNA-SF评估是否具有比正常营养患者的死亡风险更高(CHI(2)= 15.728,P <0.001; CHI(2)= 7.039 ,p = 0.008分别)。年龄,血清白蛋白水平和NRS2002得分是影响死亡率的独立因素。结论MNA-SF评分可能比NRS2002得分更好,以识别中国老年大菌群的康迟腺。 NRS2002和MNA-SF分数都可以预测死亡率,但NRS2002得分是独立的预测因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号